Corresponding author: Bruce Sullivan. Correspondence through the editorial office: official@truethink.org.
Changing exposure records, longitudinal decisions, documentation create distinct evidence obligations in maternal-infant evidence communication. This literature-based conceptual analysis does not report a new experiment. The focal evidence concerns how evidence concerning HIV, pregnancy, and infant feeding should be interpreted in ongoing clinical communication. Records collected at different times do not automatically describe the same decision state. Medication, exposure, symptoms, and evidence availability can change between observations. Inspect timestamp gaps and define permissible windows. Compare contemporaneous and stale combinations and report whether interpretation changes when alignment is tightened. The proposed comparison concerns changing exposure records, longitudinal decisions, documentation; it would test whether the specific failure scenario is detected without erasing legitimate uncertainty. Implications are restricted to the evidence roles relevant to maternal-infant evidence communication, leaving broader efficacy and deployment claims unresolved.
HIV, Pregnancy, and Infant Feeding asks how evidence concerning HIV, pregnancy, and infant feeding should be interpreted in ongoing clinical communication (Xiao Yu et al. 2026c). Its methodological basis is a JAMA correspondence contribution rather than a newly reported cohort or randomized intervention. The accessible evidence is specific: the bibliographic record establishes a short correspondence item; inaccessible full-text details are not reconstructed or treated as clinical recommendations. Its relevance is the role of clinical discussion in identifying interpretation and communication obligations around sensitive longitudinal decisions. The correspondence does not provide independent new trial evidence here; this review offers no individualized HIV or feeding advice. For temporal alignment, the important connection is the distinction between changing exposure records and documentation. The source informs that distinction, but a stronger conclusion would require evidence at the point where one is used to stand for the other.
The sources should be compared through the roles they play, not merged into a single performance claim. HIV, Pregnancy, and Infant Feeding addresses how evidence concerning HIV, pregnancy, and infant feeding should be interpreted in ongoing clinical communication (Xiao Yu et al. 2026c). That difference matters for temporal alignment: the evidence concerning changing exposure records is not automatically evidence concerning documentation. A successful software operation, a plausible mechanistic account, and a validated outcome are different achievements. Their integration may improve traceability, but it cannot create an unmeasured link. A coherent review should identify where the sources complement one another and where their scopes remain incompatible. Here the proposed failure scenario is a stale record used in a time-sensitive discussion. The analytical value of that scenario is that it can occur without requiring any cited paper to be wrong: an otherwise valid local finding can be misused at a later interface. Preventing that misuse requires evidence about the interface itself, not simply a larger collection of local results.
A narrow reading of medication histories, feeding histories, and data time reveals a broader problem of evidence design. The question is what an informed user can conclude from changing exposure records when documentation remains uncertain. Consider the possibility of a stale record used in a time-sensitive discussion. This is a proposed stress scenario, not an observed event reported by the cited studies. Its purpose is to expose which evidence contract would be violated even if the final output looked plausible. For clinical correspondence and changing patient records, the relevant claim must identify its population or artifact class, its time window, and the action it is supposed to support. A failure at any of these levels may persist even after a local technical improvement. The analysis therefore treats published methods as bounded evidence and asks how their limitations interact with this particular decision. An operational analogy is useful only if it keeps those limitations visible.
Records collected at different times do not automatically describe the same decision state. Medication, exposure, symptoms, and evidence availability can change between observations. Combining them needs a justified temporal window. In this article, the relevant contrast is changing exposure records, longitudinal decisions, documentation. The proposed counterexample of a stale record used in a time-sensitive discussion puts that contrast under pressure. Inspect timestamp gaps and define permissible windows. Compare contemporaneous and stale combinations and report whether interpretation changes when alignment is tightened. A favorable finding would show that the intended interpretation of documentation remains defensible when changing exposure records is perturbed under the specified conditions. An unfavorable finding should narrow the claim rather than be discarded as an inconvenient case.
A reviewer of medication histories, feeding histories, and data time should be able to recover a claim before judging an output. The illustrative case is a stale record used in a time-sensitive discussion. The input record should retain enough information to decide which part of that scenario violates the intended contract. That includes the original source type, measurement or artifact status, and the reason the proposed interpretation exceeds its support. The evaluator would compare the system's response with a qualified judgment made without seeing that response. Disagreement should be classified rather than erased by rewriting the prompt. Combining them needs a justified temporal window. A useful negative result would show that the interface cannot preserve this distinction under realistic use; a useful positive result would demonstrate preservation on independent cases rather than merely on the example used to develop the rule. The primary source remains relevant through its particular contribution: Its relevance is the role of clinical discussion in identifying interpretation and communication obligations around sensitive longitudinal decisions. That contribution should be retained even if the integrated workflow fails. Conversely, successful integration would not remove the source's limitations or turn a proposed extension into an already observed result. This asymmetric interpretation protects both the literature and the user from an unjustified all-or-nothing verdict.
Selective prediction formalizes abstention when evidence does not support action (Geifman and El-Yaniv 2017). Abstention creates a tradeoff between coverage and residual error. Comparing systems without matching coverage can make one look safer merely because it leaves more work unfinished. Deferred cases also consume human or computational resources. The evaluation should show the risk-coverage relation and account for the fate of excluded cases, rather than treating them as though they have ceased to matter. For the comparison involving changing exposure records, longitudinal decisions, documentation, the source supplies an analytical obligation. The review's proposed application remains a hypothesis, with the deliberately difficult scenario serving as a check on scope inflation.
Feature attribution can guide audit but does not establish biological causality (Lundberg and Lee 2017). Attribution decomposes a model output according to a defined explanatory convention. That decomposition can reveal dependence on suspicious features without establishing why the outcome occurs in the world. Reference choices and feature dependence can affect interpretation. A useful audit should compare explanations with known model behavior and should not transform a feature contribution into a treatment or mechanism claim. The connection to medication histories, feeding histories, and data time is a constraint on interpretation. It would be inappropriate to borrow the source's methodological authority as direct confirmation of the integrated domain claim.
Health-AI governance requires accountability, transparency, inclusion, and protection of autonomy (World Health Organization 2021). Health-AI governance concerns people affected by a system as well as the organization operating it. Transparency without a route to challenge an output is incomplete. Autonomy and inclusion require attention to who can obtain follow-up, who is represented in evaluation, and who bears false alarms. These obligations remain even when an assistance tool is described as advisory rather than decisive. An implementation should expose this limitation to reviewers of clinical correspondence and changing patient records. The result and its evidence qualification should remain recoverable even when the interface condenses them into a short report.
Replication and transparent workflows are prerequisites for reliable biomedical claims (National Academies 2019). Reproducing a calculation and independently replicating a finding are different achievements. Recoverable data and code allow one to inspect the first; independent observations and design choices inform the second. A review should avoid calling several reanalyses of one dataset separate replications. Clear reporting of analysis changes also makes a failed replication informative instead of allowing it to disappear as an implementation dispute. An implementation should expose this limitation to reviewers of clinical correspondence and changing patient records. The result and its evidence qualification should remain recoverable even when the interface condenses them into a short report.
FAIR principles support reusable cohorts, signals, and analysis metadata (Wilkinson et al. 2016). Reusable evidence needs more than a downloadable file. Identifiers, metadata, provenance, and meaningful access conditions help another researcher determine what an artifact contains and whether it can answer a new question. Reuse does not mean universal permission or universal scientific comparability. The information needed to judge those boundaries should travel with the artifact rather than remain in private workflow knowledge. An implementation should expose this limitation to reviewers of clinical correspondence and changing patient records. The result and its evidence qualification should remain recoverable even when the interface condenses them into a short report.
Causal inference requires a clearly specified intervention, time order, and exchangeability assumptions (Hernán and Robins 2020). A prediction can be accurate without identifying what an intervention would change. A useful causal analysis begins by defining the hypothetical comparison, eligibility, and time zero. Its assumptions concern the process generating exposure and observation, not merely the flexibility of a fitted model. In this review, causal vocabulary is appropriate only when that comparison can be specified and defended. The connection to medication histories, feeding histories, and data time is a constraint on interpretation. It would be inappropriate to borrow the source's methodological authority as direct confirmation of the integrated domain claim.
Epidemiologic design makes confounding, selection, and measurement error part of interpretation (Rothman, Greenland, and Lash 2008). Confounding, selection, and measurement error are distinct problems and need not move an estimate in the same direction. An analysis should describe them before deciding which adjustment is adequate. A larger dataset can reduce random error while leaving systematic error almost untouched. Precision should therefore be interpreted alongside the quality of the design and the eligibility of its population. An implementation should expose this limitation to reviewers of clinical correspondence and changing patient records. The result and its evidence qualification should remain recoverable even when the interface condenses them into a short report.
False-discovery control is central when many molecular features are screened (Benjamini and Hochberg 1995). Multiplicity arises from the family of questions actually searched. Controlling false discoveries within a named family does not automatically cover later tissue filters, alternative endpoints, or narrative choices. The proposed audit should retain exploratory branches so the family is visible. Independent confirmation then addresses a different question from whether a discovery threshold was correctly applied during screening. Within maternal-infant evidence communication, this distinction is relevant to temporal alignment. The proposed failure scenario is a stale record used in a time-sensitive discussion; its evaluation must preserve the original source's methodological scope.
Medical machine learning must fit data provenance, care pathways, and prospective evaluation (Rajkomar, Dean, and Kohane 2019). The clinical relevance of a model depends on how its output changes a care process. Development data can contain information that becomes available only after the intended decision. A review must identify that availability boundary before comparing algorithms. Prospective use also changes who is measured and who is treated, so evaluation of a frozen historical dataset cannot establish the entire future workflow. The connection to medication histories, feeding histories, and data time is a constraint on interpretation. It would be inappropriate to borrow the source's methodological authority as direct confirmation of the integrated domain claim.
Responsible health AI connects prediction with workflow, monitoring, and patient impact (Wiens et al. 2019). The point at which a model reaches practice is not the end of evaluation. New populations, changing measurements, and feedback can alter failure modes. A responsible deployment needs a route for recognizing deterioration and a person authorized to respond. Monitoring should be linked to feasible corrective actions; an alert that cannot change the workflow provides accountability only in a very limited sense. For the comparison involving changing exposure records, longitudinal decisions, documentation, the source supplies an analytical obligation. The review's proposed application remains a hypothesis, with the deliberately difficult scenario serving as a check on scope inflation.
Inspect timestamp gaps and define permissible windows. Compare contemporaneous and stale combinations and report whether interpretation changes when alignment is tightened. This would operationalize the concern with temporal alignment rather than assume it has been resolved by one successful output. These procedures are proposed, not completed. The case set would include the scenario of a stale record used in a time-sensitive discussion, with its validity judged independently of the system's response. The relevant comparison axes are changing exposure records, longitudinal decisions, documentation.
A timing-focused protocol would preserve issue, acquisition, exposure, and outcome clocks separately. Reviewers would identify the information available at each decision and compare conclusions before and after later information is introduced. The key contrast is whether a claim changes because the underlying state changes or because the analysis has borrowed a future observation. Retrospective reconstruction and prospective use must receive different labels.
The correspondence contribution should remain a source of interpretive questions, not a dataset of treatment outcomes. A source-review study can assess whether summaries preserve that role. A separate clinical or measurement study would be required to test patient outcomes, with professional oversight and appropriate ethical design. No automated-review score would substitute for that independent evidence.
Access limits are material for HIV, Pregnancy, and Infant Feeding. Where only bibliographic scope or a limited abstract is available, the discussion does not assign unverified datasets, algorithms, effect sizes, or clinical recommendations. This review is a bounded conceptual synthesis rather than a systematic review with an exhaustive search protocol. It cannot establish the effectiveness of the proposed integrated workflow. Its specific contribution is to articulate how temporal alignment changes the interpretation of changing exposure records, longitudinal decisions, documentation. Technical sources support computational comparisons only; they do not validate biological mechanisms or patient benefit. Reviews and correspondence retain their publication roles and are not counted as new experiments. Proposed stress cases are illustrative, not observed failures attributed to the papers. Future work should therefore test the weakest inference described here, preserve contrary results, and disclose the cost of checking rather than treating additional automation as intrinsically beneficial.
Changing exposure records deserves to remain distinguishable from documentation. That distinction is the central safeguard identified by this review. Inspect timestamp gaps and define permissible windows. Compare contemporaneous and stale combinations and report whether interpretation changes when alignment is tightened. The primary source remains bounded by its own design: The correspondence does not provide independent new trial evidence here; this review offers no individualized HIV or feeding advice. The cited studies provide useful but different forms of support. Their integration should increase traceability and expose missing links, leaving clinical, mechanistic, and operational claims at the strength justified by their own evidence.
1. Yu, Xiao, et al. “HIV, Pregnancy, and Infant Feeding.” JAMA, vol. 336, no. 2, 2026, p. 169, https://doi.org/10.1001/jama.2026.6033.
2. Geifman, Yonatan, and Ran El-Yaniv. “Selective Classification for Deep Neural Networks.” Advances in Neural Information Processing Systems, vol. 30, 2017.
3. Lundberg, Scott M., and Su-In Lee. “A Unified Approach to Interpreting Model Predictions.” Advances in Neural Information Processing Systems, vol. 30, 2017.
4. World Health Organization. Ethics and Governance of Artificial Intelligence for Health. World Health Organization, 2021.
5. National Academies of Sciences, Engineering, and Medicine. Reproducibility and Replicability in Science. National Academies Press, 2019.
6. Wilkinson, Mark D., et al. “The FAIR Guiding Principles for Scientific Data Management and Stewardship.” Scientific Data, vol. 3, 2016, article 160018.
7. Hernán, Miguel A., and James M. Robins. Causal Inference: What If. Chapman & Hall/CRC, 2020.
8. Rothman, Kenneth J., Sander Greenland, and Timothy L. Lash. Modern Epidemiology. 3rd ed., Lippincott Williams & Wilkins, 2008.
9. Benjamini, Yoav, and Yosef Hochberg. “Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing.” Journal of the Royal Statistical Society: Series B, vol. 57, no. 1, 1995, pp. 289–300.
10. Rajkomar, Alvin, Jeffrey Dean, and Isaac Kohane. “Machine Learning in Medicine.” New England Journal of Medicine, vol. 380, 2019, pp. 1347–58.
11. Wiens, Jenna, et al. “Do No Harm: A Roadmap for Responsible Machine Learning for Health Care.” Nature Medicine, vol. 25, 2019, pp. 1337–40.